The group shares perspectives, insights and questions on four key topics: diagnostics (including both non-invasive technologies and AI/machine learning), drug development, patient populations and policy.Mixed in here you will find discussions on food insecurity, polygenic risk and multi-disciplinary medicine. A great session to hear if you are still organizing your takeaways and questions emerging from the Congress.
TOPICS: Akero Therapeutics, cirrhosis, Diabetes, EchoSens, efruxifermin, FIB-4, FibroScan, inventiva, lanifibranor, Madrigal, MRI-PDFF, NAFLD, NASH, non-invasive liver testing, Novo Nordisk, Obesity, Semaglutide, social policy, TrialDesign, resmetirom, food insecurity, canigliflozin, Janssen Pharma, LITMUS consortium, MRE,Real World Evidence
Surfing The NASH Tsunami is brought to you by HEP Dynamics
#HEPdynamics #SurfingNASH #podcast
